Want to join the conversation?
$WAT, which competes with $PKI and $TMO, said the company's pharmaceutical market led the way with 12% growth in 2Q16. The company saw good growth in its core small molecule QA/QC as well as in large molecule R&D oriented applications. On product line dynamics, instrument sales grew 7% with positive demand for core LC and bench top LC-MS platforms.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.